business
1trial
Hyderabad, India
Therapeutic Areas
Immune system disorders
Diseases
Asthma
Interventions
Fluticasone Furoate
Sponsors (2 505)
search
business
1trial
Stuttgart, Germany
Therapeutic Areas
Surgical and medical procedures
Diseases
Chemotherapy cardiotoxicity attenuation
Interventions
Daunorubicin Hydrochloride
business
1trial
Neuilly-sur-Seine, France
Therapeutic Areas
Hepatobiliary disorders
Diseases
Alcoholic liver disease
business
1trial
Cadempino, Switzerland
Therapeutic Areas
Nervous system disorders
Diseases
Parkinson's disease
Interventions
Benserazide Hydrochloride
2trials
North melbourne, Australia
Therapeutic Areas
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Diseases
Glioblastoma
Interventions
4-IODOPHENYLALANINE I-131
business
2trials
Ljubljana, Slovenia
Therapeutic Areas
Congenital, familial and genetic disorders
Diseases
Colon cancer
Interventions
Bleomycin Sulfate Ph. Eur.
business
1trial
Madrid, Spain
Therapeutic Areas
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Diseases
Breast cancer female
business
1trial
Ann Arbor, United States
Therapeutic Areas
Immune system disorders
Diseases
Dermatitis atopic
Interventions
Lebrikizumab
business
1trial
Therapeutic Areas
Cardiac disorders
Diseases
Chronic coronary syndrome
Interventions
Acetylsalicylic Acid
business
1trial
Minato, Japan
Therapeutic Areas
Infections and infestations
Diseases
Adenovirus infection
Interventions
Anhydrous Cidofovir
business
Dublin, Ireland
business
1trial
Pisa, Italy
Therapeutic Areas
Metabolism and nutrition disorders
Diseases
Iron deficiency
business
1trial
Tampere, Finland
Therapeutic Areas
Cardiac disorders
Diseases
Acute myocardial infarction
Interventions
Amoxicillin Trihydrate
business
Mechelen, Belgium
business
1trial
Solna, Sweden
Therapeutic Areas
Blood and lymphatic system disorders
Diseases
Haematological malignancy
Interventions
Idarubicin Hydrochloride
Need more than the directory?
Competitive positioning, market entry, partnership opportunities — tell us the question.